Metabolic profile response to administration of epigallocatechin-3-gallate in high-fat-fed mice
Autor(a) principal: | |
---|---|
Data de Publicação: | 2014 |
Outros Autores: | , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNIFESP |
Texto Completo: | http://dx.doi.org/10.1186/1758-5996-6-84 http://repositorio.unifesp.br/handle/11600/38086 |
Resumo: | Background: Obesity is associated with increased adipose tissue and glucose intolerance. High-fat diets (HFDs) are known to induce obesity and increase proinflammatory adipokines. the consumption of green tea may improve the health of obese individuals because it contains a potent antioxidant that has effects on body weight, energy expenditure and serum cholesterol concentrations.Methods: We examined the effects of epigallocatechin-3-gallate (EGCG) (50 mg/kg body weight per day) or saline after 30 or 60 days of treatment. Mice were distributed into four groups: 1) NS: normolipidic diet receiving saline; 2) NE: normolipidic diet receiving EGCG; 3) HFS: high-fat diet receiving saline; 4) HFE: high-fat diet receiving EGCG.Results: We observed that administration of a HFD plus EGCG treatment for 60 days reduced delta weight, the relative weights of the mesenteric adipose tissue (MES), retroperitonial adipose tissue (RET), epididymal adipose tissue (EPI), the sum of the adipose tissues (SAT), reduced triacylglycerol (TG) and improved both high-density lipoprotein (HDL) cholesterol levels and the adiponectin/STA ratio when compared with HFS.Conclusions: Our results suggest that the chronic administration of EGCG (60 days) promoted a significant improvement in glucose tolerance, decreased adipose tissue deposits, weight mass, TG and HDL-C only when associated with high-fat diet treatment. |
id |
UFSP_530e98e4abc60ccec5db52ab7d8ce487 |
---|---|
oai_identifier_str |
oai:repositorio.unifesp.br/:11600/38086 |
network_acronym_str |
UFSP |
network_name_str |
Repositório Institucional da UNIFESP |
repository_id_str |
3465 |
spelling |
Metabolic profile response to administration of epigallocatechin-3-gallate in high-fat-fed miceHigh-fat dietAdipokinesAdipose tissueInflammationBackground: Obesity is associated with increased adipose tissue and glucose intolerance. High-fat diets (HFDs) are known to induce obesity and increase proinflammatory adipokines. the consumption of green tea may improve the health of obese individuals because it contains a potent antioxidant that has effects on body weight, energy expenditure and serum cholesterol concentrations.Methods: We examined the effects of epigallocatechin-3-gallate (EGCG) (50 mg/kg body weight per day) or saline after 30 or 60 days of treatment. Mice were distributed into four groups: 1) NS: normolipidic diet receiving saline; 2) NE: normolipidic diet receiving EGCG; 3) HFS: high-fat diet receiving saline; 4) HFE: high-fat diet receiving EGCG.Results: We observed that administration of a HFD plus EGCG treatment for 60 days reduced delta weight, the relative weights of the mesenteric adipose tissue (MES), retroperitonial adipose tissue (RET), epididymal adipose tissue (EPI), the sum of the adipose tissues (SAT), reduced triacylglycerol (TG) and improved both high-density lipoprotein (HDL) cholesterol levels and the adiponectin/STA ratio when compared with HFS.Conclusions: Our results suggest that the chronic administration of EGCG (60 days) promoted a significant improvement in glucose tolerance, decreased adipose tissue deposits, weight mass, TG and HDL-C only when associated with high-fat diet treatment.Universidade Federal de São Paulo, EPM, Dept Fisiol, São Paulo, BrazilFac Integradas Coracao Jesus FAINC, Santo Andre, SP, BrazilUniv Estadual Paulista, UNESP, Dept Phys Educ, Immunometab Res Grp, Presidente Prudente, SP, BrazilUniv Southern Santa Catarina, Hlth Sci Unit, Lab Exercise Biochem & Physiol, Criciuma, SC, BrazilUniversidade Federal de São Paulo, Dept Ciencias Biol, Diadema, SP, BrazilUniversidade Federal de São Paulo, EPM, Dept Fisiol, São Paulo, BrazilUniversidade Federal de São Paulo, Dept Ciencias Biol, Diadema, SP, BrazilWeb of ScienceFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)FAINCFAPESP: 2009/14373-8Biomed Central LtdUniversidade Federal de São Paulo (UNIFESP)Fac Integradas Coracao Jesus FAINCUniv Estadual PaulistaUniv Southern Santa CatarinaMoreno, Mayara Franzoi [UNIFESP]De Laquila, Rachel [UNIFESP]Okuda, Marcos Hiromu [UNIFESP]Lira, Fabio Santos de [UNIFESP]Souza, Gabriel Inacio de Morais Honorato de [UNIFESP]Souza, Claudio Teodoro deTelles, Monica Marques [UNIFESP]Ribeiro, Eliane Beraldi [UNIFESP]Nascimento, Claudia Maria da Penha Oller do [UNIFESP]Oyama, Lila Missae [UNIFESP]2016-01-24T14:37:43Z2016-01-24T14:37:43Z2014-08-12info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion7application/pdfhttp://dx.doi.org/10.1186/1758-5996-6-84Diabetology & Metabolic Syndrome. London: Biomed Central Ltd, v. 6, 7 p., 2014.10.1186/1758-5996-6-84WOS000340957000002.pdf1758-5996http://repositorio.unifesp.br/handle/11600/38086WOS:000340957000002engDiabetology & Metabolic Syndromeinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-08T16:00:37Zoai:repositorio.unifesp.br/:11600/38086Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-08-08T16:00:37Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false |
dc.title.none.fl_str_mv |
Metabolic profile response to administration of epigallocatechin-3-gallate in high-fat-fed mice |
title |
Metabolic profile response to administration of epigallocatechin-3-gallate in high-fat-fed mice |
spellingShingle |
Metabolic profile response to administration of epigallocatechin-3-gallate in high-fat-fed mice Moreno, Mayara Franzoi [UNIFESP] High-fat diet Adipokines Adipose tissue Inflammation |
title_short |
Metabolic profile response to administration of epigallocatechin-3-gallate in high-fat-fed mice |
title_full |
Metabolic profile response to administration of epigallocatechin-3-gallate in high-fat-fed mice |
title_fullStr |
Metabolic profile response to administration of epigallocatechin-3-gallate in high-fat-fed mice |
title_full_unstemmed |
Metabolic profile response to administration of epigallocatechin-3-gallate in high-fat-fed mice |
title_sort |
Metabolic profile response to administration of epigallocatechin-3-gallate in high-fat-fed mice |
author |
Moreno, Mayara Franzoi [UNIFESP] |
author_facet |
Moreno, Mayara Franzoi [UNIFESP] De Laquila, Rachel [UNIFESP] Okuda, Marcos Hiromu [UNIFESP] Lira, Fabio Santos de [UNIFESP] Souza, Gabriel Inacio de Morais Honorato de [UNIFESP] Souza, Claudio Teodoro de Telles, Monica Marques [UNIFESP] Ribeiro, Eliane Beraldi [UNIFESP] Nascimento, Claudia Maria da Penha Oller do [UNIFESP] Oyama, Lila Missae [UNIFESP] |
author_role |
author |
author2 |
De Laquila, Rachel [UNIFESP] Okuda, Marcos Hiromu [UNIFESP] Lira, Fabio Santos de [UNIFESP] Souza, Gabriel Inacio de Morais Honorato de [UNIFESP] Souza, Claudio Teodoro de Telles, Monica Marques [UNIFESP] Ribeiro, Eliane Beraldi [UNIFESP] Nascimento, Claudia Maria da Penha Oller do [UNIFESP] Oyama, Lila Missae [UNIFESP] |
author2_role |
author author author author author author author author author |
dc.contributor.none.fl_str_mv |
Universidade Federal de São Paulo (UNIFESP) Fac Integradas Coracao Jesus FAINC Univ Estadual Paulista Univ Southern Santa Catarina |
dc.contributor.author.fl_str_mv |
Moreno, Mayara Franzoi [UNIFESP] De Laquila, Rachel [UNIFESP] Okuda, Marcos Hiromu [UNIFESP] Lira, Fabio Santos de [UNIFESP] Souza, Gabriel Inacio de Morais Honorato de [UNIFESP] Souza, Claudio Teodoro de Telles, Monica Marques [UNIFESP] Ribeiro, Eliane Beraldi [UNIFESP] Nascimento, Claudia Maria da Penha Oller do [UNIFESP] Oyama, Lila Missae [UNIFESP] |
dc.subject.por.fl_str_mv |
High-fat diet Adipokines Adipose tissue Inflammation |
topic |
High-fat diet Adipokines Adipose tissue Inflammation |
description |
Background: Obesity is associated with increased adipose tissue and glucose intolerance. High-fat diets (HFDs) are known to induce obesity and increase proinflammatory adipokines. the consumption of green tea may improve the health of obese individuals because it contains a potent antioxidant that has effects on body weight, energy expenditure and serum cholesterol concentrations.Methods: We examined the effects of epigallocatechin-3-gallate (EGCG) (50 mg/kg body weight per day) or saline after 30 or 60 days of treatment. Mice were distributed into four groups: 1) NS: normolipidic diet receiving saline; 2) NE: normolipidic diet receiving EGCG; 3) HFS: high-fat diet receiving saline; 4) HFE: high-fat diet receiving EGCG.Results: We observed that administration of a HFD plus EGCG treatment for 60 days reduced delta weight, the relative weights of the mesenteric adipose tissue (MES), retroperitonial adipose tissue (RET), epididymal adipose tissue (EPI), the sum of the adipose tissues (SAT), reduced triacylglycerol (TG) and improved both high-density lipoprotein (HDL) cholesterol levels and the adiponectin/STA ratio when compared with HFS.Conclusions: Our results suggest that the chronic administration of EGCG (60 days) promoted a significant improvement in glucose tolerance, decreased adipose tissue deposits, weight mass, TG and HDL-C only when associated with high-fat diet treatment. |
publishDate |
2014 |
dc.date.none.fl_str_mv |
2014-08-12 2016-01-24T14:37:43Z 2016-01-24T14:37:43Z |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1186/1758-5996-6-84 Diabetology & Metabolic Syndrome. London: Biomed Central Ltd, v. 6, 7 p., 2014. 10.1186/1758-5996-6-84 WOS000340957000002.pdf 1758-5996 http://repositorio.unifesp.br/handle/11600/38086 WOS:000340957000002 |
url |
http://dx.doi.org/10.1186/1758-5996-6-84 http://repositorio.unifesp.br/handle/11600/38086 |
identifier_str_mv |
Diabetology & Metabolic Syndrome. London: Biomed Central Ltd, v. 6, 7 p., 2014. 10.1186/1758-5996-6-84 WOS000340957000002.pdf 1758-5996 WOS:000340957000002 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Diabetology & Metabolic Syndrome |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
7 application/pdf |
dc.publisher.none.fl_str_mv |
Biomed Central Ltd |
publisher.none.fl_str_mv |
Biomed Central Ltd |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UNIFESP instname:Universidade Federal de São Paulo (UNIFESP) instacron:UNIFESP |
instname_str |
Universidade Federal de São Paulo (UNIFESP) |
instacron_str |
UNIFESP |
institution |
UNIFESP |
reponame_str |
Repositório Institucional da UNIFESP |
collection |
Repositório Institucional da UNIFESP |
repository.name.fl_str_mv |
Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP) |
repository.mail.fl_str_mv |
biblioteca.csp@unifesp.br |
_version_ |
1814268272397254656 |